phaseollidin has been researched along with rk 682 in 1 studies
| Studies (phaseollidin) | Trials (phaseollidin) | Recent Studies (post-2010) (phaseollidin) | Studies (rk 682) | Trials (rk 682) | Recent Studies (post-2010) (rk 682) |
|---|---|---|---|---|---|
| 6 | 0 | 2 | 23 | 0 | 9 |
| Protein | Taxonomy | phaseollidin (IC50) | rk 682 (IC50) |
|---|---|---|---|
| Cytochrome P450 3A4 | Homo sapiens (human) | 4.6 | |
| Cytochrome P450 2D6 | Homo sapiens (human) | 4.6 | |
| Tyrosine-protein phosphatase non-receptor type 2 | Homo sapiens (human) | 5.1 | |
| Tyrosine-protein phosphatase non-receptor type 1 | Homo sapiens (human) | 4.4357 | |
| M-phase inducer phosphatase 2 | Mus musculus (house mouse) | 3.65 | |
| Delta-type opioid receptor | Mus musculus (house mouse) | 4.5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dao, TT; Kang, KW; Le, TV; Mbafor, JT; Ndinteh, DT; Nguyen, PH; Oh, WK; Thuong, PT | 1 |
1 other study(ies) available for phaseollidin and rk 682
| Article | Year |
|---|---|
Cytotoxic and PTP1B inhibitory activities from Erythrina abyssinica.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Drug Design; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Erythrina; Humans; Molecular Structure; Plant Bark; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Stereoisomerism | 2009 |